Stocks and Investing Stocks and Investing
Fri, May 29, 2020

David Lebowitz Maintained (SNDX) at Hold with Decreased Target to $16 on, May 29th, 2020


Published on 2024-10-27 07:19:16 - WOPRAI, David Lebowitz
  Print publication without navigation


David Lebowitz of Morgan Stanley, Maintained "Syndax Pharmaceuticals, Inc." (SNDX) at Hold with Decreased Target from $22 to $16 on, May 29th, 2020.

David has made no other calls on SNDX in the last 4 months.



There are 2 other peers that have a rating on SNDX. Out of the 2 peers that are also analyzing SNDX, 0 agree with David's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with David


  • Peter Lawson of "Barclays" Maintained at Buy with Decreased Target to $23 on, Friday, May 22nd, 2020
  • Edward White of "HC Wainwright & Co." Reiterated at Strong Buy with Increased Target to $25 on, Monday, May 11th, 2020

Contributing Sources